Related Articles
Preclinical trial of the multi-targeted lenvatinib in combination with cellular immunotherapy for treatment of renal cell carcinoma
Contrast‑enhanced computerized tomography combined with a targeted nanoparticle contrast agent for screening for early‑phase non‑small cell lung cancer
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo
Combined effects of Lenvatinib and iodine‑131 on cell apoptosis in nasopharyngeal carcinoma through inducing endoplasmic reticulum stress
Estimation of tumor microvessel density by MRI using a blood pool contrast agent